Media

All media enquiries should be directed to: Carol Moore of Moore PR T: (02) 9560 2826 M: 0402 382 363 E: carolmoore@moorepr.com.au

This page displays recent media items. For older media items, please visit the media archive.

28 June 2018 EXPERT REACTION: Senate report on allowing ‘three person IVF’ to prevent mitochondrial disease
Read about expert reactions to the Senate Report on mitochondrial donation.


22 June 2018 Stealth Raises $100M to Advance Elamipretide as Treatment for Mitochondrial Diseases
Further development of Elamipretide as treatment for Leber’s hereditary optic neuropathy (LHON), mitochondrial myopathy, Barth syndrome, and age-related macular degeneration.


4 May 2018 FDA Grants NeuroVive’s KL1333 Orphan Drug Status for Treatment of Mitochondrial Diseases
Orphan Drug Designation of compound KL1333 is a positive step towards bringing such treatment to patients of inherited mitochondrial respiratory chain diseases in the US.


30 April 2018 Stealth BioTherapeutics Granted Orphan Drug Designation for Elamipretide for Treatment of Leber’s Hereditary Optic Neuropathy
Orphan Drug Designation of investigational treatment for Leber’s hereditary optic neuropathy (LHON) is one step further to bringing such treatment to LHON patients in the US.


9 April 2018 Stealth BioTherapeutics Granted Orphan Drug Designation for Elamipretide for Treatment of Barth Syndrome
Orphan Drug Designation of Elamipretide will help bring this treatment from the laboratory to Barth syndrome patients.


5 April 2018 Mounting Evidence Links Mitochondrial DNA to Autism
Spectrum media release on US studies that suggest several types of genetic alterations in the mitochondrial DNA, that may affect mitochondrial function, increase the risk of autism spectrum disorder (ASD).


5 April 2018 Online DNA Kits Bring Risks and Rewards
ABC media release on potential risks of direct-to-consumer DNA kits.


28 March 2018 Inquiry Calls for Moratorium on the Use of Genetic Test Results for Life Insurance
Monash University media release on the Parliamentary Inquiry Report recommendations for a moratorium on the use of genetic information by Australian life insurers.


19 March 2018 Google Maps’ Latest Update Makes it Easier for Wheelchair Users to get Around
AWOL media release about Google Maps’ new feature which displays wheelchair accessible routes in cities around the world, including Sydney.


6 March 2018 Stealth BioTherapeutics Completes Enrollment of Study for the Treatment of Barth syndrome
Media release on Stealth BioTherapeutics’ TAZPOWER clinical trial in the USA, a study evaluating elamipretide as treatment for patients with genetically confirmed Barth syndrome.


1 March 2018 Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study of Omaveloxolone in Patients with Mitochondrial Mypothies
Media release on findings from biopharmaceutical company REATA’s clinical trial on treatment (maveloxolone) for patients with mitochondrial myopathies.


27 February 2018 Victorian Clinical Genetics Services and Edico Genome Deploy First DRAGEN Bio-IT Platform in Australia
Edico Genome media release about the Murdoch Children’s Research Institute’s (MCRI) Victorian Clinical Genetics Services (VCGS) partnering with Edico Genome to reduce the turnaround time of genomic testing results in Australia.


2 February 2018 Women undergo mitochondrial donation in the UK
The Mito Foundation is delighted that mitochondrial donation has become a reality for two women in the UK.


27 November 2017 Khondrion’s phase II clinical trial results
Media release from Dutch pharmaceutical company, Khondrion, detailing the preliminary results of their phase II KHENERGY study.


5 September 2017 AMDF’s Global Mitochondrial Disease Awareness Week initiatives
Media release on the Mito Foundation’s Awareness Week 2017 events, including Light Up for Mito and Stay in Bed Day.


7 August 2017 Research into mitochondrial disease diagnosis
Media release on a new genetic testing approach that could improve diagnosis for mitochondrial disease.


25 July 2017 The Mito Foundation statement on the plight of baby Charlie Gard
A statement from the Mito Foundation CEO Sean Murray regarding the need for more research funding in the wake of baby Charlie’s plight.


23 June 2017 AMDF’s response to Senator Hanson’s comments
AMDF’s response to Senator Pauline Hanson’s comments regarding the education of children with disabilities.


1 June 2017 INSPIRE article on genomic sequencing
Research Australia’s INSPIRE magazine article that discusses why pursuing a diagnosis of mitochondrial disease is important, and how genomic sequencing can improve diagnoses in Australia.


24 May 2017 RCPA article on the Mito Foundation-AGHA partnership
Royal College of Pathologists of Australasia monthly newsletter article that discusses the Mito Foundation’s partnership with the Australian Genomic Health Alliance, and how the project this project will enable every person with a strong suspicion of mito to gain a definitive diagnosis via genetic testing.


17 March 2017 First clinical mitochondrial donation licence granted in UK
The Mito Foundation media release regarding the first clinical mitochondrial donation licence in the UK. The Mito Foundation applauds the announcement as a major step forward for the global mitochondrial disease community.


16 January 2017 News.com.au story on the Beard family
A story about Pippa and Tony Beard. The Beard family have a history of mito, with Pippa being severely affected. Pippa’s sister Toby experiences mild symptoms and would love have a child of her own. Mitochondrial donation could ensure that she doesn’t pass on this debilitating disease to her future child.

 


The Mito Foundation media release regarding the latest updates from the Human Fertilisation and Embryology Authority (HFEA). The HFEA have officially authorised the use of mitochondrial donation in the UK. The Mito Foundation hopes that the Australian government will follow suit and legalise the IVF technique.